Selected article for: "complement activation and cytokine storm"
Author: Mahmudpour, Mehdi; Roozbeh, Jamshid; Keshavarz, Mohsen; Farrokhi, Shokrollah; Nabipour, Iraj
Title: COVID-19 cytokine storm: The anger of inflammation
  • Cord-id: 8241pjpe
  • Document date: 2020_5_30
    • ID: 8241pjpe
    Snippet: Patients with COVID-19 who require ICU admission might have the cytokine storm. It is a state of out-of-control release of a variety of inflammatory cytokines. The molecular mechanism of the cytokine storm has not been explored extensively yet. The attachment of SARS-CoV-2 spike glycoprotein with angiotensin-converting enzyme 2 (ACE2), as its cellular receptor, triggers complex molecular events that leads to hyperinflammation. Four molecular axes that may be involved in SARS-CoV-2 driven inflamm
    Document: Patients with COVID-19 who require ICU admission might have the cytokine storm. It is a state of out-of-control release of a variety of inflammatory cytokines. The molecular mechanism of the cytokine storm has not been explored extensively yet. The attachment of SARS-CoV-2 spike glycoprotein with angiotensin-converting enzyme 2 (ACE2), as its cellular receptor, triggers complex molecular events that leads to hyperinflammation. Four molecular axes that may be involved in SARS-CoV-2 driven inflammatory cytokine overproduction are addressed in this work. The virus-mediated down-regulation of ACE2 causes a burst of inflammatory cytokine release through dysregulation of the renin-angiotensin-aldosterone system (ACE/angiotensin II/AT1R axis), attenuation of Mas receptor (ACE2/MasR axis), increased activation of [des-Arg9]-bradykinin (ACE2/bradykinin B1R/DABK axis), and activation of the complement system including C5a and C5b-9 components. The molecular clarification of these axes will elucidate an array of therapeutic strategies to confront the cytokine storm in order to prevent and treat COVID-19 associated acute respiratory distress syndrome.

    Search related documents:
    Co phrase search for related documents
    • ace angiotensin and activated protein kinases: 1
    • ace angiotensin and activation cytokine storm: 1, 2, 3
    • ace angiotensin and active product: 1
    • ace angiotensin and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace angiotensin and acute lung failure: 1, 2, 3, 4, 5, 6, 7
    • ace angiotensin ii and activated protein kinases: 1
    • ace angiotensin ii and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • ace angiotensin ii and acute lung failure: 1, 2, 3, 4, 5
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute lung failure: 1
    • activated protein kinases and acute ards respiratory distress syndrome: 1
    • activation cytokine storm and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • activation machinery and acute ards respiratory distress syndrome: 1, 2
    • active product and acute ards respiratory distress syndrome: 1